Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 12 |
GO:0042995 | cell projection | 2 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 12 |
Related structures:
AlphaFold database: A4HMZ8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 129 | 133 | PF00656 | 0.521 |
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.238 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.402 |
CLV_NRD_NRD_1 | 225 | 227 | PF00675 | 0.603 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.230 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.248 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.521 |
CLV_PCSK_KEX2_1 | 225 | 227 | PF00082 | 0.672 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.339 |
DEG_SCF_FBW7_1 | 242 | 247 | PF00400 | 0.503 |
DEG_SPOP_SBC_1 | 177 | 181 | PF00917 | 0.651 |
DOC_MAPK_gen_1 | 20 | 27 | PF00069 | 0.493 |
DOC_MAPK_MEF2A_6 | 39 | 46 | PF00069 | 0.482 |
DOC_PP4_FxxP_1 | 144 | 147 | PF00568 | 0.562 |
DOC_SPAK_OSR1_1 | 109 | 113 | PF12202 | 0.448 |
DOC_USP7_MATH_1 | 114 | 118 | PF00917 | 0.448 |
DOC_USP7_MATH_1 | 170 | 174 | PF00917 | 0.516 |
DOC_USP7_MATH_1 | 177 | 181 | PF00917 | 0.562 |
DOC_USP7_MATH_1 | 197 | 201 | PF00917 | 0.751 |
DOC_USP7_MATH_1 | 217 | 221 | PF00917 | 0.666 |
DOC_USP7_MATH_1 | 244 | 248 | PF00917 | 0.728 |
DOC_USP7_MATH_1 | 267 | 271 | PF00917 | 0.569 |
DOC_WW_Pin1_4 | 240 | 245 | PF00397 | 0.642 |
DOC_WW_Pin1_4 | 283 | 288 | PF00397 | 0.609 |
LIG_14-3-3_CanoR_1 | 178 | 185 | PF00244 | 0.707 |
LIG_14-3-3_CanoR_1 | 260 | 266 | PF00244 | 0.568 |
LIG_14-3-3_CanoR_1 | 65 | 71 | PF00244 | 0.400 |
LIG_14-3-3_CanoR_1 | 87 | 92 | PF00244 | 0.379 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.386 |
LIG_DLG_GKlike_1 | 87 | 94 | PF00625 | 0.379 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.450 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.354 |
LIG_FHA_2 | 125 | 131 | PF00498 | 0.542 |
LIG_FHA_2 | 160 | 166 | PF00498 | 0.671 |
LIG_Integrin_isoDGR_2 | 211 | 213 | PF01839 | 0.672 |
LIG_Integrin_RGD_1 | 213 | 215 | PF01839 | 0.518 |
LIG_LIR_Apic_2 | 143 | 147 | PF02991 | 0.462 |
LIG_LIR_Apic_2 | 149 | 154 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 104 | 110 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 258 | 262 | PF02991 | 0.645 |
LIG_LRP6_Inhibitor_1 | 71 | 77 | PF00058 | 0.291 |
LIG_MAD2 | 279 | 287 | PF02301 | 0.522 |
LIG_SH2_CRK | 151 | 155 | PF00017 | 0.686 |
LIG_SH2_CRK | 259 | 263 | PF00017 | 0.638 |
LIG_SUMO_SIM_anti_2 | 89 | 95 | PF11976 | 0.453 |
LIG_TRAF2_1 | 127 | 130 | PF00917 | 0.539 |
LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.665 |
LIG_TRAF2_1 | 269 | 272 | PF00917 | 0.584 |
LIG_WRC_WIRS_1 | 141 | 146 | PF05994 | 0.612 |
LIG_WRC_WIRS_1 | 262 | 267 | PF05994 | 0.490 |
MOD_CDK_SPxK_1 | 240 | 246 | PF00069 | 0.680 |
MOD_CDK_SPxxK_3 | 245 | 252 | PF00069 | 0.632 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.723 |
MOD_CK1_1 | 199 | 205 | PF00069 | 0.574 |
MOD_CK1_1 | 261 | 267 | PF00069 | 0.661 |
MOD_CK1_1 | 283 | 289 | PF00069 | 0.505 |
MOD_CK1_1 | 86 | 92 | PF00069 | 0.543 |
MOD_CK2_1 | 124 | 130 | PF00069 | 0.520 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.687 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.438 |
MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.179 |
MOD_GlcNHglycan | 180 | 183 | PF01048 | 0.642 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.703 |
MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.667 |
MOD_GlcNHglycan | 300 | 303 | PF01048 | 0.629 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.586 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.634 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.721 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.449 |
MOD_N-GLC_1 | 94 | 99 | PF02516 | 0.225 |
MOD_N-GLC_2 | 26 | 28 | PF02516 | 0.344 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.371 |
MOD_NEK2_1 | 296 | 301 | PF00069 | 0.611 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.454 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.509 |
MOD_PIKK_1 | 27 | 33 | PF00454 | 0.424 |
MOD_PKA_2 | 130 | 136 | PF00069 | 0.379 |
MOD_PKA_2 | 177 | 183 | PF00069 | 0.542 |
MOD_PKA_2 | 64 | 70 | PF00069 | 0.418 |
MOD_PKA_2 | 86 | 92 | PF00069 | 0.379 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.708 |
MOD_Plk_4 | 261 | 267 | PF00069 | 0.472 |
MOD_ProDKin_1 | 240 | 246 | PF00069 | 0.644 |
MOD_ProDKin_1 | 283 | 289 | PF00069 | 0.600 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.471 |
TRG_ENDOCYTIC_2 | 259 | 262 | PF00928 | 0.642 |
TRG_ER_diArg_1 | 107 | 109 | PF00400 | 0.448 |
TRG_ER_diArg_1 | 19 | 21 | PF00400 | 0.522 |
TRG_ER_diArg_1 | 224 | 226 | PF00400 | 0.710 |
TRG_NES_CRM1_1 | 17 | 31 | PF08389 | 0.382 |
TRG_NES_CRM1_1 | 33 | 45 | PF08389 | 0.345 |
TRG_Pf-PMV_PEXEL_1 | 124 | 128 | PF00026 | 0.369 |
TRG_Pf-PMV_PEXEL_1 | 77 | 81 | PF00026 | 0.284 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJM3 | Leptomonas seymouri | 61% | 99% |
A0A0S4JGU9 | Bodo saltans | 41% | 96% |
A0A1X0P674 | Trypanosomatidae | 48% | 96% |
A0A3S7X9J5 | Leishmania donovani | 80% | 100% |
A0A422N788 | Trypanosoma rangeli | 48% | 100% |
A4IBM1 | Leishmania infantum | 80% | 100% |
C9ZZ14 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9AFF5 | Leishmania major | 79% | 100% |
E9B6L0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 100% |
V5DUQ3 | Trypanosoma cruzi | 48% | 100% |